TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TMDX TransMedics Group, Inc.

Post-Mkt 09-17 17:24:00 EDT

86.66

-0.90

-1.03%

盘后87.00

+0.34+0.39%

17:20 EDT

High89.41	Low85.47	Vol690.55K
Open88.00	D1 Closing87.56	Amplitude4.51%
Mkt Cap2.99B	Tradable Cap2.88B	Total Shares34.54M
T/O59.68M	T/O Rate2.08%	Tradable Shares33.28M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TMDX","market":"US","secType":"STK","nameCN":"TransMedics Group, Inc.","latestPrice":86.66,"timestamp":1789675200000,"preClose":87.56,"halted":0,"volume":690549,"hourTrading":{"tag":"盘后","latestPrice":87,"preClose":86.66,"latestTime":"17:20 EDT","volume":27728,"amount":2402926.7804799997,"timestamp":1789680000119,"change":0.34,"changeRate":0.003923,"amplitude":0.014078},"delay":0,"changeRate":-0.010278666057560594,"floatShares":33275683,"shares":34544158,"eps":4.017144,"marketStatus":"Post-Mkt","change":-0.9,"latestTime":"09-17 17:24:00 EDT","open":88,"high":89.41,"low":85.465,"amount":59683010.66415,"amplitude":0.045055,"askPrice":87,"askSize":35,"bidPrice":86.17,"bidSize":18,"shortable":3,"etf":0,"ttmEps":4.017144,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789689600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1556769600000,"exchange":"NASDAQ","adjPreClose":87.56,"preHourTrading":{"tag":"盘前","latestPrice":88.14,"preClose":87.56,"latestTime":"09:29 EDT","volume":838,"amount":73582.5593,"timestamp":1789651799999,"change":0.58,"changeRate":0.006624,"amplitude":0.009137},"postHourTrading":{"tag":"盘后","latestPrice":87,"preClose":86.66,"latestTime":"17:20 EDT","volume":27728,"amount":2402926.7804799997,"timestamp":1789680000119,"change":0.34,"changeRate":0.003923,"amplitude":0.014078},"volumeRatio":0.82401,"impliedVol":0.5498,"impliedVolPercentile":0.2032},"requestUrl":"/m/hq/s/TMDX/wiki","defaultTab":"wiki","newsList":[{"id":"2666521521","title":"Canaccord Genuity Keeps Their Buy Rating on TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666521521","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666521521?lang=en_us&edition=fundamental","pubTime":"2026-09-11 19:36","pubTimestamp":1789126564,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst William Plovanic maintained a Buy rating on TransMedics Group today and set a price target of $95.00. Plovanic covers the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666515072","title":"TransMedics Names Fernando Araujo CFO, Effective Sept. 21","url":"https://stock-news.laohu8.com/highlight/detail?id=2666515072","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666515072?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:41","pubTimestamp":1789072875,"startTime":"0","endTime":"0","summary":"TransMedics names Fernando Araujo CFO, effective Sept. 21TransMedics named Fernando Araujo chief financial officer effective Sept. 21, 2026.Araujo most recently served as CFO of GE HealthCare’s Advanc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL19MMyV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","BK4588","BK4585","TMDX","LU2065731478.USD","GEHC","LU2324357040.USD","BK4082","LU0124676726.USD","LU0689626769.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666156515","title":"TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2666156515","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666156515?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:22","pubTimestamp":1789071770,"startTime":"0","endTime":"0","summary":"Sept 10 (Reuters) - TransMedics Group, Inc.::*TRANSMEDICS APPOINTS FERNANDO ARAUJO AS CHIEF FINANCIAL OFFICER AND REITERATES 2026 FINANCIAL OUTLOOK((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 10-SEP-202620:05:00.03 GMT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nRSD2TSNjy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2324357040.USD","TMDX","BK4588","BK4082","LU2065731478.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666851567","title":"GUIDANCE: (TMDX) TransMedics Expects Full Year 2026 Revenue Range $737M - $757M, vs. FactSet Est of $743.1M","url":"https://stock-news.laohu8.com/highlight/detail?id=2666851567","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666851567?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:19","pubTimestamp":1789071558,"startTime":"0","endTime":"0","summary":"GUIDANCE: (TMDX) TransMedics Expects Full Year 2026 Revenue Range $737M - $757M, vs. FactSet Est of $743.1M","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666737513","title":"TransMedics Reiterates 2026 Revenue Outlook of $737 Million-$757 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666737513","media":"Reuters","labels":["executive","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666737513?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:07","pubTimestamp":1789070876,"startTime":"0","endTime":"0","summary":"TransMedics reiterates 2026 revenue outlook of $737 million-$757 millionTransMedics reiterated full-year 2026 revenue guidance of $737 million to $757 million.Outlook implies about 22% to 25% year-ove","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDL7wT3Pg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU2065731478.USD","BK4585","BK4588","TMDX","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666158165","title":"Transmedics Group, - Gerardo Hernandez to Transition to Commercial Strategic Advisor, Latam","url":"https://stock-news.laohu8.com/highlight/detail?id=2666158165","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666158165?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:05","pubTimestamp":1789070700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nPLXP3DH68:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","TMDX","LU2324357040.USD","LU2065731478.USD","BK4588","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666134355","title":"Transmedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2666134355","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666134355?lang=en_us&edition=fundamental","pubTime":"2026-09-11 04:05","pubTimestamp":1789070700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA5LHBRM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TMDX","BK4588","BK4585","BK4082","LU2065731478.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664260888","title":"TransMedics to Present at Morgan Stanley Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664260888","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664260888?lang=en_us&edition=fundamental","pubTime":"2026-09-01 04:07","pubTimestamp":1788206859,"startTime":"0","endTime":"0","summary":"TransMedics to present at Morgan Stanley Global Healthcare Conference fireside chatTransMedics will join a fireside chat at Morgan Stanley’s 24th Annual Global Healthcare Conference on Sept. 14, 2026 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL6mnjL5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4082","BK4588","LU2324357040.USD","TMDX","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662762381","title":"TransMedics (TMDX) Stock Looks Below Fair Value Though Governance Risks Weigh","url":"https://stock-news.laohu8.com/highlight/detail?id=2662762381","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662762381?lang=en_us&edition=fundamental","pubTime":"2026-08-26 10:26","pubTimestamp":1787711188,"startTime":"0","endTime":"0","summary":"TransMedics Group stock has delivered a strong 5 year gain, yet the broader valuation checks currently suggest the shares still lean cheap relative to fundamentals. Recent share price swings and legal headlines mean investors are weighing that high value score against fresh questions about governance and risk.\n\nOver the past 5 years, TransMedics Group has returned about 186.4%, which puts recent setbacks into a longer history of strong shareholder gains.\nAn ongoing investigation into...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/transmedics-tmdx-stock-looks-below-fair-value-though-governa","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-tmdx/transmedics-group/news/transmedics-tmdx-stock-looks-below-fair-value-though-governa","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","TMDX","VOTE","LU2324357040.USD","LU2065731478.USD","DECU","GXDW","JOYT","BK4588","RGLO","PMDE","FEBU","BK4082","VGFPF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659165757","title":"Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS Pathways (CMPS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659165757","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659165757?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:40","pubTimestamp":1786635611,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on TransMedics Group (TMDX), Spyre Therapeutics (SYRE) and COMPASS P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-spyre-therapeutics-syre-and-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-transmedics-group-tmdx-spyre-therapeutics-syre-and-compass-pathways-cmps-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4581","TMDX","CMPS","HCSG","XLV","LU0128526141.USD","SYRE","XBI","BK4082","LFSC","LU2065731478.USD","PSIL","BK4137","LABU","BK4588","BK4585","LU2324357040.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658943714","title":"TransMedics Rilis Presentasi Soal Teknologi Perfusi Organ Portabel Dan Jaringan Layanan-Logistik Transplantasi Nasional","url":"https://stock-news.laohu8.com/highlight/detail?id=2658943714","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658943714?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:31","pubTimestamp":1786480286,"startTime":"0","endTime":"0","summary":"TransMedics rilis presentasi soal teknologi perfusi organ portabel dan jaringan layanan-logistik transplantasi nasionalTransmedics Group Inc. menegaskan strategi memperluas pemanfaatan organ transplan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL8MSjPt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4588","LU2324357040.USD","BK4585","TMDX","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657267805","title":"TransMedics Group Price Target Cut to $100.00/Share from $120.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2657267805","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657267805?lang=en_us&edition=fundamental","pubTime":"2026-08-06 00:12","pubTimestamp":1785946320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TMDX/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4585","BK4588","LU2324357040.USD","LU2065731478.USD","TMDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657470115","title":"UBS Adjusts Price Target on TransMedics Group to $77 From $80, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2657470115","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657470115?lang=en_us&edition=fundamental","pubTime":"2026-08-05 21:15","pubTimestamp":1785935751,"startTime":"0","endTime":"0","summary":"TransMedics Group (TMDX) has an average rating of overweight and mean price target of $97.30, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","TMDX","BK4082","LU2324357040.USD","BK4585","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657054939","title":"TransMedics price target lowered to $95 from $124 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2657054939","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657054939?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:20","pubTimestamp":1785928852,"startTime":"0","endTime":"0","summary":"Canaccord lowered the firm’s price target on TransMedics (TMDX) to $95 from $124 and keeps a Buy rating on the shares. The firm said they reported ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transmedics-price-target-lowered-to-95-from-124-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transmedics-price-target-lowered-to-95-from-124-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065731478.USD","BK4585","TMDX","BK4082","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657590939","title":"Transmedics Group, Inc. : Canaccord Genuity Cuts Target Price to $95 from $124","url":"https://stock-news.laohu8.com/highlight/detail?id=2657590939","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657590939?lang=en_us&edition=fundamental","pubTime":"2026-08-05 13:33","pubTimestamp":1785908001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nFWN4420LC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","LU2065731478.USD","BK4585","BK4588","TMDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657598278","title":"Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA) and TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657598278","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657598278?lang=en_us&edition=fundamental","pubTime":"2026-08-05 07:00","pubTimestamp":1785884418,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on IDEAYA Biosciences (IDYA) and TransMedics Group (TMD...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ideaya-biosciences-idya-and-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ideaya-biosciences-idya-and-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU2324357040.USD","BK4585","LU2065731478.USD","LABU","LU0029874061.USD","HCSG","XBI","BK4139","BK4581","XLV","TMDX","IDYA","LU0128526141.USD","BK4137","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657560390","title":"Transmedics Group Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657560390","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657560390?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:37","pubTimestamp":1785879471,"startTime":"0","endTime":"0","summary":"Transmedics Group Inc reports results for the quarter ended June 30 - Earnings SummaryTransmedics Group IncTMDX.OQreported quarterly adjusted earnings of 44 cents per share for the quarter ended June ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N44139C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2065731478.USD","LU2324357040.USD","BK4585","TMDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657562612","title":"TransMedics Q2 Net Income Declines on R&D and Infrastructure Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2657562612","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657562612?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:44","pubTimestamp":1785876276,"startTime":"0","endTime":"0","summary":"TransMedics Q2 net income declines on R&D and infrastructure expensesOverviewUS organ transplant tech firm's Q2 revenue rose 21%, beating analyst expectationsAdjusted EPS for Q2 was $0.44; no analyst ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL1N441174:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4175","UFPT","AHCO","LU2065731478.USD","BK4585","BK4136","BK4198","VMD","BK4082","BK4588","TMDX","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657643055","title":"TransMedics Q2 FY26 GAAP Net Income Drops 58% to USD 14.7 Million; Revenue Rises 21% to USD 189.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657643055","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657643055?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:26","pubTimestamp":1785875213,"startTime":"0","endTime":"0","summary":"TransMedics Q2 FY26 GAAP net income drops 58% to USD 14.7 million; revenue rises 21% to USD 189.9 millionTransMedics posted Q2 2026 revenue of USD 189.9 million, up 21% from a year earlier.GAAP net in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL9rXrbV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","LU2324357040.USD","LU2065731478.USD","TMDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657356920","title":"TransMedics Gr Q2 Adj. EPS $0.44 Misses $0.47 Estimate, Sales $189.948M Beat $183.635M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657356920","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657356920?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:08","pubTimestamp":1785874130,"startTime":"0","endTime":"0","summary":"TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.44 per share which missed the analyst consensus estimate of $0.47 by 6.38 percent. This is a 52.17 percent decrease over earnings of $0.92 per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60929003/transmedics-gr-q2-adj-eps-0-44-misses-0-47-estimate-sales-189-948m-beat-183-635m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"TransMedics Gr Q2 Adj. EPS $0.44 Misses $0.47 Estimate, Sales $189.948M Beat $183.635M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","TMDX","BK4585","LU2065731478.USD","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transmedics.com","stockEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":-0.0089},{"period":"3month","weight":0.1113},{"period":"6month","weight":-0.2313},{"period":"1year","weight":-0.2651},{"period":"ytd","weight":-0.2802}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0241},{"period":"3month","weight":0.0098},{"period":"6month","weight":0.1626},{"period":"1year","weight":0.1425},{"period":"ytd","weight":0.1058}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.026649},{"month":2,"riseRate":0.714286,"avgChangeRate":0.153587},{"month":3,"riseRate":0.285714,"avgChangeRate":-0.028866},{"month":4,"riseRate":0.714286,"avgChangeRate":0.095218},{"month":5,"riseRate":0.428571,"avgChangeRate":0.061567},{"month":6,"riseRate":0.875,"avgChangeRate":0.137203},{"month":7,"riseRate":0.5,"avgChangeRate":0.007949},{"month":8,"riseRate":0.625,"avgChangeRate":0.04902},{"month":9,"riseRate":0.25,"avgChangeRate":-0.080578},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.144574},{"month":11,"riseRate":0.857143,"avgChangeRate":0.223183},{"month":12,"riseRate":0.428571,"avgChangeRate":-0.026786}],"exchange":"NASDAQ","name":"TransMedics Group, Inc.","nameEN":"TransMedics Group, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TransMedics Group, Inc.,TMDX,TransMedics Group, Inc.股票,TransMedics Group, Inc.股票老虎,TransMedics Group, Inc.股票老虎国际,TransMedics Group, Inc.行情,TransMedics Group, Inc.股票行情,TransMedics Group, Inc.股价,TransMedics Group, Inc.股市,TransMedics Group, Inc.股票价格,TransMedics Group, Inc.股票交易,TransMedics Group, Inc.股票购买,TransMedics Group, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TransMedics Group, Inc.(TMDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TransMedics Group, Inc.(TMDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}